Chemoinformaics analysis of Heptadecanoic acid
| Molecular Weight | 270.457 | nRot | 15 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 10 |
| Exact Molecular Weight | 270.256 | nRing | 0 |
| Solubility: LogS | -5.318 | nHRing | 0 |
| Solubility: LogP | 4.617 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 52.665 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.648 |
| Synth | 3.174 |
| Natural Product Likeliness | 0.709 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.047 |
| Pgp-sub | 0.014 |
| HIA | 0.003 |
| CACO-2 | -4.49 |
| MDCK | 0.0000139 |
| BBB | 0.677 |
| PPB | 0.959095 |
| VDSS | 2.572 |
| FU | 0.0453786 |
| CYP1A2-inh | 0.808 |
| CYP1A2-sub | 0.918 |
| CYP2c19-inh | 0.895 |
| CYP2c19-sub | 0.88 |
| CYP2c9-inh | 0.85 |
| CYP2c9-sub | 0.6 |
| CYP2d6-inh | 0.458 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.594 |
| CYP3a4-sub | 0.724 |
| CL | 7.6 |
| T12 | 0.167 |
| hERG | 0.382 |
| Ames | 0.042 |
| ROA | 0.088 |
| SkinSen | 0.379 |
| Carcinogencity | 0.177 |
| EI | 0.082 |
| Respiratory | 0.363 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.667567 |